Source: Eur Respir J 2014; 44: 324-331
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sanchez-Salcedo Pablo, Divo Miguel, Casanova Ciro, Pinto-Plata Victor, de-Torres Juan P., Cote Claudia, Cabrera Carlos, Zagaceta Jorge, Rodriguez-Roisin Roberto, Zulueta Javier J., Marin Jose Maria, Celli Bartolome. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model. Eur Respir J 2014; 44: 324-331

Member's Comments

No comment yet.

Related content which might interest you: The natural history of COPD: confirming and going beyond Fletcher and Peto Source: Eur Respir J 2014; 44: 280-283 Year: 2014 Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021 Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 COPD: CardiOPulmonary Disease? Source: Eur Respir J 2013; 41: 1241-1243 Year: 2013 Disease severity in COPD patients Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003 Disease progression patterns in COPD Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 Investigation of sarcopenia in Japanese COPD patients Source: International Congress 2015 – Latest insights into chronic care Year: 2015 COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study Source: International Congress 2017 – Markers of COPD progression Year: 2017 Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study Source: Eur Respir J 2013; 41: 548-555 Year: 2013 Disease specific knowledge in Tunisian COPD patients Source: International Congress 2018 – COPD around the world Year: 2018 GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort: Disease management in primary care: Descriptive data Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Do GOLD stages of COPD severity really correspond to differences in health status? Source: Eur Respir J 2003; 22: 444-449 Year: 2003 Does Nutritional Risk Screening 2002 correlate with  dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study. Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017